VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE Read more about VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE US Application 17/850,706Filed on 2022-06-27
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES Read more about VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES US Application 17/851,905Filed on 2022-06-28
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Australia2022246465Filed on 2022-10-07
Novel Multivalent Nanoparticle-Based Vaccines Read more about Novel Multivalent Nanoparticle-Based Vaccines Israel294189Filed on 2022-06-21
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Vietnam1-2022-02013Filed on 2016-10-24
MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE Read more about MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE South Africa2022/06497Filed on 2020-12-11
Recombinant Prefusion Measles And Mumps F And F-HN Glycoproteins And Their Use Read more about Recombinant Prefusion Measles And Mumps F And F-HN Glycoproteins And Their Use US Application 17/784,605Filed on 2022-06-10
MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE Read more about MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE Singapore11202250095UFiled on 2020-12-11
MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE Read more about MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE New Zealand789242Filed on 2020-12-11
MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE Read more about MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE South Korea10-2022-7023549Filed on 2020-12-11